Estimates Revisions Spyre Therapeutics, Inc.
Stocks
SYRE
US00773J2024
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
16:00:00 2026-09-02 EDT
|
5-day change | 1st Jan Change | ||
| 87.05 USD | -1.64% |
|
-7.00% | +165.72% |
| 08-26 | Top Midday Decliners | MT |
| 08-26 | U.S. research roundup- Intuit, MongoDB, Zscaler | RE |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | - | - | ||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Stocks
- SYRE Stock
- Consensus Spyre Therapeutics, Inc.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
